Clinical Trials Browser

Withdrawn × Pancreatic Neoplasms × epacadostat × Clear all

NCT03432676 2019-05-30

Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms